Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias
- 1 May 1991
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 67 (11) , 976-980
- https://doi.org/10.1016/0002-9149(91)90170-p
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group.Circulation, 1991
- Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.Circulation, 1989
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Designing clinical trials for paroxysmal atrial tachycardia and other paroxysmal arrhythmiasJournal of Clinical Epidemiology, 1987
- The spontaneous occurrence of paroxysmal supraventricular tachycardia.Circulation, 1984
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Statistical Methods for Poisson Processes and Exponential PopulationsJournal of the American Statistical Association, 1954